MeiraGTx’s AAV-AIPL1 has already led to vision gains in blind children, as regulatory submissions for the gene therapy close ...

In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn ...

Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced it has entered into a patent license agreement with Shandong ...

From revolutionary CRISPR treatment to heavy drinking dangers, here's what you need to know about the latest health research.

Researchers from Skoltech, the University of Potsdam, and the Massachusetts Institute of Technology have discovered a ...

MeiraGTx Holdings has signed a deal with Eli Lilly , potentially worth over $475 million, granting the pharma giant rights to ...

A new study by researchers at the Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, has found that some ...

Police in Las Vegas say help from Calgary police has aided them in identifying a victim of an apparent homicide almost 50 ...

In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol ...

A study harnessing a successful treatment for lymphoma and applying it to other cancers promises a breakthrough in how to attack a range of tumours using the body’s own immune system.

Eli Lilly stock reached a new 52-week high on Nov. 10, up 4.7% and extending a month-long rally of 16%, after the ...

A research team from the University of Osaka, in collaboration with the Massachusetts Institute of Technology, has uncovered ...